Cargando…

The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis

BACKGROUND: Several recent reports have demonstrated that tyrosine (Y)-methionine (M)-aspartic acid (D)-aspartic acid (D) (YMDD) motif mutations can naturally occur in chronic HBV patients without antiviral treatment such as lamivudine therapy. This paper aims to assess the overall spontaneous incid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Youwen, Ding, Keqin, Su, Jing, Trinh, Xuan, Peng, Zhihang, Gong, Yuhua, Chen, Li, Cui, Qian, Lei, Na, Chen, Xin, Yu, Rongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314000/ https://www.ncbi.nlm.nih.gov/pubmed/22479339 http://dx.doi.org/10.1371/journal.pone.0032789

Ejemplares similares

YMDD motif mutation after lamivudine therapy
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2011)

Detection of YMDD Motif Mutants by Oligonucleotide Chips in Lamivudine-Untreated Patients with Chronic Hepatitis B Virus Infection
por: Heo, Jeong, et al.
Publicado: (2004)

The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis
por: He, Min, et al.
Publicado: (2015)

Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus
por: Liu, Hongcan, et al.
Publicado: (2021)

Novel mutation in YMDD motif and direct neighbourhood in a child with chronic HBV-infection and clinical lamivudine and adefovir resistance - a scholarly case
por: Schildgen, Verena, et al.
Publicado: (2010)

Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
por: Wang, Changtai, et al.
Publicado: (2019)

Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection
por: Ghandehari, Freshte, et al.
Publicado: (2011)

YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy
por: Rahimi, Rahim, et al.
Publicado: (2015)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

Compensatory variances of drug-induced hepatitis B virus YMDD mutations
por: Cai, Ying, et al.
Publicado: (2016)

Natural YMDD motif mutations in treatment naïve patients with chronic hepatitis B in Huzhou of eastern China
por: Qian, Fuchu, et al.
Publicado: (2016)

Lamivudine treatment for severe acute HBV hepatitis
por: Lisotti, Andrea, et al.
Publicado: (2008)

Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China
por: Li, Si-Yue, et al.
Publicado: (2011)

Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
por: Luo, Aoran, et al.
Publicado: (2018)

HBV Genotype B/C and Response to Lamivudine Therapy: A Systematic Review
por: Chen, Xiu-Li, et al.
Publicado: (2013)

A Novel Hydrodynamic Injection Mouse Model of HBV Genotype C for the Study of HBV Biology and the Anti-Viral Activity of Lamivudine
por: Li, Xiumei, et al.
Publicado: (2016)

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
por: Stewart, Balint, et al.
Publicado: (2011)

Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
por: Lee, Hye Won, et al.
Publicado: (2020)

The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy
por: Cai, Qingqing, et al.
Publicado: (2016)

Detection of rtN236T mutation associated with adefovir dipivoxil resistance in Hepatitis B infected patients with YMDD mutations in Tehran
por: Monavari, Seyed Hamidreza, et al.
Publicado: (2013)

Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis
por: Gao, Xiaofei, et al.
Publicado: (2011)

Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history
por: Zhu, Yuan O., et al.
Publicado: (2017)

HBV infection in untreated HIV-infected adults in Maputo, Mozambique
por: Chambal, Lúcia Mabalane, et al.
Publicado: (2017)

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients
por: Nakamuta, Makoto, et al.
Publicado: (2007)

Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients
por: Mello, Francisco C A, et al.
Publicado: (2012)

Naturally occurring genotypic drug-resistant mutations of HBV in Huzhou, China: a single-center study
por: Qian, Fuchu, et al.
Publicado: (2017)

Correction: HBV infection in untreated HIV-infected adults in Maputo, Mozambique
por: Chambal, Lúcia Mabalane, et al.
Publicado: (2017)

Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand
por: Khamduang, Woottichai, et al.
Publicado: (2012)

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
por: Costantini, Andrea, et al.
Publicado: (2011)

Evaluation of adefovir & lamivudine in chronic hepatitis B: Correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis
por: Pradeep, Kumar S, et al.
Publicado: (2011)

Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine
por: Yasutake, Yoshiaki, et al.
Publicado: (2020)

Naturally Occurring Mutations within HBV Surface Promoter II Sequences Affect Transcription Activity, HBsAg and HBV DNA Levels in HBeAg-Positive Chronic Hepatitis B Patients
por: Hao, Ran, et al.
Publicado: (2019)

Spontaneous tumor lysis syndrome occurring in untreated uterine cancer
por: Berger, Rachel, et al.
Publicado: (2017)

Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
por: Santos, Eneida A, et al.
Publicado: (2004)

Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data
por: Rodriguez, Allan E, et al.
Publicado: (2010)

Efficacy of Lamivudine or Entecavir against Virological Rebound after Achieving HBV DNA Negativity in Chronic Hepatitis B Patients
por: Miyauchi, Tomoo, et al.
Publicado: (2013)

Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
por: Chen, En-Qiang, et al.
Publicado: (2009)

Natural History of Untreated Retinoblastoma
por: Zhao, Junyang, et al.
Publicado: (2021)

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy
por: Momiyama, Koichi, et al.
Publicado: (2015)

Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China
por: Su, Mingze, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_usb1nlaf4c53mttkfe3c456im7